Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income
Preferred stock
Warrants
Accumulated deficit
Beginning Balance at Jun. 30, 2018 $ 5,435,223 $ 2,297 $ 43,198,193 $ 21,178 $ 6,425,410 $ 8,229,482 $ (52,441,337)
Beginning Balance, shares at Jun. 30, 2018   2,296,667          
Issuance of shares and warrants - net of issue costs 2,386,171 $ 1,170 2,332,102     52,899  
Issuance of shares and warrants - net of issue costs, shares   1,170,000          
Exercise and exchange of warrants 720,165 $ 297 2,930,565     (2,210,697)  
Exercise and exchange of warrants, shares   296,667          
Conversion of Series B preferred stock to common stock   $ 52 1,447,524   (1,447,576)    
Conversion of Series B preferred stock to common stock, shares   51,876          
Reclassification of derivative liability to equity 492,884         492,884  
Shares issued for services 13,777 $ 3 13,774        
Shares issued for services, shares   3,444          
Warrants issued for services 23,715         23,715  
Shares issued on reverse stock split 2 $ 2          
Shares issued on reverse stock split, shares   2,433          
Stock option expense 426,029   426,029        
Performance stock unit expense 526,141   526,141        
Series A preferred cash dividend (8,356)           (8,356)
Series B preferred stock dividend   $ 18 80,413       (80,431)
Series B preferred stock dividend, shares   18,271          
Loss for the year (8,048,221)           (8,048,221)
Ending Balance at Jun. 30, 2019 1,967,530 $ 3,839 50,954,741 21,178 4,977,834 6,588,283 (60,578,345)
Ending Balance, shares at Jun. 30, 2019   3,839,358          
Issuance of shares and warrants - net of issue costs 6,582,966 $ 4,895 2,489,251     4,088,820  
Issuance of shares and warrants - net of issue costs, shares   4,895,000          
Exercise of pre-funded warrants for cash 26,550 $ 2,655 2,421,830     (2,397,935)  
Exercise of pre-funded warrants for cash, shares   2,655,000          
Exercise of warrants for cash 25,000 $ 25 37,113     (12,138)  
Exercise of warrants for cash, shares   25,000          
Conversion of Series B preferred stock to common stock   $ 6 174,401   (174,407)    
Conversion of Series B preferred stock to common stock, shares   6,250          
Shares issued for services 13,396 $ 23 13,373        
Shares issued for services, shares   22,520          
Warrants issued for services 287,183         287,183  
Warrants expired     29,877     (29,877)  
Stock option expense 494,861   494,861        
Series A preferred cash dividend (8,356)           (8,356)
Series B preferred stock dividend   $ 15 8,601       (8,616)
Series B preferred stock dividend, shares   14,800          
Loss for the year (9,125,916)           (9,125,916)
Ending Balance at Jun. 30, 2020 $ 263,214 $ 11,458 $ 56,624,048 $ 21,178 $ 4,803,427 $ 8,524,336 $ (69,721,233)
Ending Balance, shares at Jun. 30, 2020   11,457,928